Renal and Hepatic Impairment (Ep. 59)
Today’s episode is a discussion of renal and hepatic impairment. I review the biology of the kidney and liver and how we analyze pharmacokinetic data to assess their impact on drug exposure. Links discussed in the show:You can connect with me on LinkedIn and send me a message Send me a message Sign up for my newsletter Copyright Teuscher Solutions LLCAll Rights Reserved
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Clinical Pharmacology Podcast with Nathan Teuscher
Beyond Small Molecules—Allometric Scaling for Biologics and Engineered mAbs (Ep. 58)
Bioequivalence Testing: The Stats Behind Generic Drug Approvals (Ep. 57)
Examining Volume of Distribution (Ep. 56)
Talking about data science with Mike Stackhouse (Ep. 55)
Get summaries like this every morning.
Free AI-powered recaps of Clinical Pharmacology Podcast with Nathan Teuscher and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.